Trexquant Investment’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-41,173
Closed -$22.1M 1735
2025
Q2
$22.1M Buy
+41,173
New +$19.7M 0.25% 76
2024
Q4
Sell
-34,812
Closed -$17.6M 1684
2024
Q3
$17.6M Sell
34,812
-50,584
-59% -$24.6M 0.22% 108
2024
Q2
$41.6M Buy
85,396
+68,115
+394% +$34.2M 0.63% 7
2024
Q1
$9.33M Sell
17,281
-10,952
-39% -$5.99M 0.19% 132
2023
Q4
$15.7M Buy
28,233
+26,299
+1,360% +$12.3M 0.35% 46
2023
Q3
$846K Sell
1,934
-45,457
-96% -$22.7M 0.02% 815
2023
Q2
$23.8M Buy
47,391
+45,670
+2,654% +$21.9M 0.62% 15
2023
Q1
$861K Sell
1,721
-3,514
-67% -$1.68M 0.02% 790
2022
Q4
$2.14M Sell
5,235
-10,507
-67% -$4.08M 0.06% 392
2022
Q3
$5.13M Sell
15,742
-42,267
-73% -$15.5M 0.18% 149
2022
Q2
$20.3M Buy
+58,009
New +$23.7M 0.91% 4
2021
Q4
Sell
-2,108
Closed -$1.31M 1438
2021
Q3
$1.31M Sell
2,108
-69
-3% -$46.4K 0.1% 268
2021
Q2
$1.38M Sell
2,177
-4,756
-69% -$2.63M 0.12% 240
2021
Q1
$3.39M Buy
+6,933
New +$3.47M 0.31% 73
2020
Q4
Sell
-7,608
Closed -$2.99M 1229
2020
Q3
$2.99M Buy
+7,608
New +$2.81M 0.19% 138
2020
Q1
Sell
-13,915
Closed -$3.63M 1259
2019
Q4
$3.63M Buy
13,915
+286
+2% +$75.4K 0.22% 147
2019
Q3
$3.71M Sell
13,629
-3,683
-21% -$1.02M 0.32% 92
2019
Q2
$4.77M Buy
+17,312
New +$4.27M 0.43% 52
2018
Q4
Sell
-15,374
Closed -$3.84M 1151
2018
Q3
$3.84M Buy
+15,374
New +$3.73M 0.29% 95
2018
Q1
Sell
-21,222
Closed -$3.32M 1215
2017
Q4
$3.32M Buy
+21,222
New +$3.34M 0.36% 40
2017
Q3
Sell
-4,800
Closed -$775K 895
2017
Q2
$775K Buy
+4,800
New +$780K 0.21% 120
2015
Q3
Sell
-19,979
Closed -$1.28M 1135
2015
Q2
$1.28M Buy
+19,979
New +$1.38M 0.14% 246

Other funds holding IDXX

Trexquant Investment's IDXX Position: Q3 2025 in Review

Trexquant Investment sold out of Idexx Laboratories (IDXX) in Q3 2025, closing a stake of 41,173 shares — an estimated $22.1M sold.

Trexquant Investment first reported a position in IDXX in Q2 2015 and held it in 22 quarters. The position peaked at $41.6M in Q2 2024. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q3 2025.

  • Trexquant Investment reported no remaining Idexx Laboratories position as of Q3 2025 after selling out during the quarter.
  • Trexquant Investment sold 41,173 Idexx Laboratories shares in Q3 2025, an estimated $22.1M.
  • Trexquant Investment first reported a position in Idexx Laboratories in Q2 2015 and held it in 22 quarters.
  • Trexquant Investment's Idexx Laboratories position peaked at $41.6M in Q2 2024.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2025.

Based on Trexquant Investment's 13F filing for Q3 2025, filed 14 Nov 2025.